PE20250746A1 - Composicion acuosa - Google Patents

Composicion acuosa

Info

Publication number
PE20250746A1
PE20250746A1 PE2024002054A PE2024002054A PE20250746A1 PE 20250746 A1 PE20250746 A1 PE 20250746A1 PE 2024002054 A PE2024002054 A PE 2024002054A PE 2024002054 A PE2024002054 A PE 2024002054A PE 20250746 A1 PE20250746 A1 PE 20250746A1
Authority
PE
Peru
Prior art keywords
aqueous composition
compositions
aqueous
wholly
polyolefin
Prior art date
Application number
PE2024002054A
Other languages
English (en)
Spanish (es)
Inventor
Rika ORITANI
Chise KITANI
Akinori Nishimoto
Original Assignee
Tsubota Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsubota Lab Inc filed Critical Tsubota Lab Inc
Publication of PE20250746A1 publication Critical patent/PE20250746A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PE2024002054A 2022-03-25 2023-03-24 Composicion acuosa PE20250746A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022050275 2022-03-25
PCT/JP2023/011739 WO2023182480A1 (ja) 2022-03-25 2023-03-24 水性組成物

Publications (1)

Publication Number Publication Date
PE20250746A1 true PE20250746A1 (es) 2025-03-13

Family

ID=88101709

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2024002054A PE20250746A1 (es) 2022-03-25 2023-03-24 Composicion acuosa

Country Status (14)

Country Link
US (1) US20250213510A1 (cg-RX-API-DMAC7.html)
EP (1) EP4483867A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023182480A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240159636A (cg-RX-API-DMAC7.html)
CN (1) CN118973561A (cg-RX-API-DMAC7.html)
AU (1) AU2023240729A1 (cg-RX-API-DMAC7.html)
CA (1) CA3254664A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002831A1 (cg-RX-API-DMAC7.html)
IL (1) IL315871A (cg-RX-API-DMAC7.html)
MA (1) MA67594B1 (cg-RX-API-DMAC7.html)
MX (1) MX2024011634A (cg-RX-API-DMAC7.html)
PE (1) PE20250746A1 (cg-RX-API-DMAC7.html)
TW (1) TW202400133A (cg-RX-API-DMAC7.html)
WO (1) WO2023182480A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026130361A1 (zh) * 2024-12-17 2026-06-25 沈阳兴齐眼药股份有限公司 药物组合物、其制备方法及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4806956B2 (ja) * 2004-04-20 2011-11-02 大正製薬株式会社 点眼用液剤
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
JP2009078977A (ja) * 2007-09-25 2009-04-16 Japan Health Science Foundation 心筋の小胞体ストレス抑制剤
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
US8962686B2 (en) * 2010-04-28 2015-02-24 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
EP2698155A1 (en) * 2012-08-16 2014-02-19 Lunamed AG Pharmaceutical unit dosage form comprising 4-phenylbutyric acid
PT3593817T (pt) 2017-03-06 2024-12-17 Tsubota Lab Inc Composição para a utilização na prevenção ou supressão da miopia
EP3603642B1 (en) * 2017-03-27 2024-01-10 Alcon Inc. Pharmaceutical preparation
CN113164421A (zh) 2018-12-18 2021-07-23 参天制药株式会社 含有4-苯基丁酸的老视的治疗或预防剂
CN111024960B (zh) * 2019-12-27 2023-02-17 广州阳普医疗科技股份有限公司 用于高血压血样检测的添加剂、试剂盒和应用

Also Published As

Publication number Publication date
EP4483867A1 (en) 2025-01-01
WO2023182480A1 (ja) 2023-09-28
US20250213510A1 (en) 2025-07-03
KR20240159636A (ko) 2024-11-05
CN118973561A (zh) 2024-11-15
MX2024011634A (es) 2024-09-30
IL315871A (en) 2024-11-01
MA67594B1 (fr) 2026-01-30
CL2024002831A1 (es) 2025-01-24
MA67594A1 (fr) 2025-07-31
EP4483867A4 (en) 2026-06-24
TW202400133A (zh) 2024-01-01
JPWO2023182480A1 (cg-RX-API-DMAC7.html) 2023-09-28
AU2023240729A1 (en) 2024-10-03
CA3254664A1 (en) 2025-07-03

Similar Documents

Publication Publication Date Title
HRP20200998T1 (hr) Postupak i sastav za liječenje okularne hipertenzije i glaukoma
HN2002000152A (es) Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco
PY2117017A (es) Ácido sulfúrico modificado y usos del mismo
ATE376423T1 (de) Gelierende wässrige pharmazeutische zusammensetzungen
PA8544401A1 (es) Metodo para fabricar una composicion farmaceutica de dosis baja que tiene una distribucion y potencia del farmaco uniformes
GT200200105A (es) Nueva composicion farmaceutica
CL2020002252A1 (es) Formulación oftálmica.
CO5580737A2 (es) Composiciones y metodos para administrar unguentos antibacterianos, antimicoticos y antivirales a las cavidades bucal, nasal o vaginal
BRPI0609636B8 (pt) formulação oral de liberação modificada que compreende um agente ativo e um revestimento entérico
AR048194A1 (es) Metodo mejorado de blanqueamiento dental
CO5251448A1 (es) Soluciones que contienen epinastina
JP2017514924A5 (cg-RX-API-DMAC7.html)
ATA2332000A (de) Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
CL2024002831A1 (es) Composicion acuosa.
PE20250835A1 (es) Composiciones y uso de la tirzepatida
MX382264B (es) Composiciones que comprenden amlodipina y bisoprolol.
MX2022007162A (es) Forma de dosificacion que comprende un agente alcalino y una capa de revestimiento enterico.
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
ECSP045110A (es) Composiciones de la preparación que contiene un compuesto fisiologicamente activo de acidos inestables y procesos para su producción
CR7730A (es) Composiciones antimicrobianas sinergeticas, con bajo contenido de formaldehido libre, estables de donadores de aldehido y acido dehidroacetico
ECSP034795A (es) "composiciones que contienen imidazotriazinona para administración nasal"
EP1641486A4 (en) Stable, aqueous solution of human erythropoietin, not containing serum albumin
PE20160904A1 (es) Combinacion triple para reduccion de presion intraocular
AR122359A1 (es) Formulaciones de fgf-21 conjugado
PY2279976A (es) Composición que contiene cariofileno